. .
Bruker Daltonics
Bruker

Scientific Posters HUPO 2011 World Congress

See examples of Bruker's new products in action for the analysis of proteins and peptides. Learn more details about the Bruker instruments and see what these products can do for you to expand the capabilities of your laboratory.

 

Poster
HUPO 2011 #P1568

Top-Down Determination of Phosphorylation Sites

Poster
HUPO 2011 #P1569

Subtractive Label-Free Quantification of Phosphorylation Sites in KAPCA-HUMAN

Poster
HUPO 2011 #P1462

Spatial Proteomics

Poster
HUPO 2011 #P1570

N-Glycosylation of Antibodies characterized by Mass Spec

Poster
HUPO 2011 #PP1840

Metabolic profiling of Myxobacterial secondary metabolites

Poster
HUPO 2011 #PP729

Metabolic profiling of a Corynebacterium glutamicum prpD2 mutant strain

Poster
HUPO 2011 #P1533

MALDI-TOF mass spectrometry in a routine microbiology department of a laboratory in Germany

Poster
HUPO 2011 #P1455

MALDI Tissue Imaging and Top-Down Sequencing for Biomarker Discovery and Identification

Poster
HUPO 2011 #P1571

Magnetic ZIC-HILIC Beads Enrichment for neutral and acidic Glycopeptides

Poster
HUPO 2011 #P1588

Isotopically Resolved FT-ICR Mass Spectrometry of Proteins Above 100 kDa at 7 Tesla

Poster
HUPO 2011 #P1643

Human cell-line phosphoproteome mapping using a dual-funnel ETD ion trap

Poster
HUPO 2011 #P1532

Automated detection of mixed cultures of microorganics from positive blood cultures using MALDI-TOF mass spectrometry

Poster
HUPO 2011 #P1586

Automated Termini Assignment of Biologics ba Top-Down MS

Poster
HUPO 2011 #PP526

A new high capacity MALDI target format facilitating improved LC-MALDI analysis

Poster
HUPO 2011 #P1731

Top-down Label-free LC-MALDI Analysis of the Peptidome

Poster
HUPO 2011 #P1331

Towards Top-Down identification, determination of sequence termini of intact proteins

Poster
HUPO 2011 #A101

Identification of 2000 proteins in single LCMSMS Runs from a cell line lysate

Poster
HUPO 2011 #P1183

A Fully Automated Solution For Quality Control Of Biological Therapeutics
 
think forward